ZENECA TO SEEK BROADER INDICATION FOR MERREM I.V.; MEROPENEM APPROVED JUNE fOG COMPLICATED INTRA-ABDOMINAL INFECTIONS, PEDIATRIC BACTERIAL MENINGITIS
Executive Summary
Zeneca is continuing discussions with FDA to seek approval of Merrem I.V. (meropenem) for broader anti-infective indications after it was granted approval for two uses June 21.